Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-aging agent for females

An anti-aging, female technology, applied in the field of female anti-aging agents, can solve problems such as poor reproductive ability

Pending Publication Date: 2022-02-01
HIROSHIMA UNIVERSITY +1
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, in the swine industry, the cycle from mating to farrowing of sows is 2.5 times per year, but as the age increases, the l

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-aging agent for females
  • Anti-aging agent for females
  • Anti-aging agent for females

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to View More

PUM

No PUM Login to View More

Abstract

The present invention pertains to an anti-aging agent for ovaries, ovarian follicles or ova, said anti-aging agent comprising pyrroloquinoline quinone or a salt thereof.

Description

technical field [0001] The invention relates to a female anti-aging agent. Background technique [0002] For women, as they grow older, reproductive tissues such as ovaries, follicles, and eggs gradually age, making it difficult to conceive or give birth. For the infertility treatment of such difficult-to-conceive women, hormone replacement therapy is mostly used to promote ovulation. However, in addition to difficulty in developing and releasing evenly mature follicles, symptoms called ovarian hyperstimulation syndrome (OHSS) may appear as a side effect, and if the symptoms worsen, there is a risk of respiratory failure or circulatory failure. Therefore, for infertility treatment, a safe and effective treatment method is being sought (Non-Patent Document 1). [0003] In addition, when the concentration of female hormones such as estrogen decreases as the female reproductive tissue ages, menopausal disorders mainly occur in women in their late 40s to their 50s. Among them...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4745A61P5/30A61P15/00A61P15/12A61P43/00
CPCA61K31/4745A61P5/30A61P15/00A61P15/12A61P43/00
Inventor 岛田昌之
Owner HIROSHIMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com